Hodge EE - Search Results

1

Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation.

Gaber AO, First MR, Tesi RJ, Gaston RS, Mendez R, Mulloy LL, Light JA, Gaber LW, Squiers E, Taylor RJ, Neylan JF, Steiner RW, Knechtle S, Norman DJ, Shihab F, Basadonna G, Brennan DC, Hodge EE, Kahan BD, Kahan L, Steinberg S, Woodle ES, Chan L, Ham JM, Schroeder TJ, et al. Gaber AO, et al. Among authors: hodge ee. Transplantation. 1998 Jul 15;66(1):29-37. doi: 10.1097/00007890-199807150-00005. Transplantation. 1998. PMID: 9679818 Clinical Trial.

2

A multicenter, open-label, comparative trial of two daclizumab dosing strategies vs. no antibody induction in combination with tacrolimus, mycophenolate mofetil, and steroids for the prevention of acute rejection in simultaneous kidney-pancreas transplant recipients: interim analysis.

Stratta RJ, Alloway RR, Hodge E, Lo A; Pancreas Investigators Vital Outcomes Trial (PIVOT) Study Group. Stratta RJ, et al. Clin Transplant. 2002 Feb;16(1):60-8. doi: 10.1034/j.1399-0012.2002.00108.x. Clin Transplant. 2002. PMID: 11982617 Clinical Trial.

3

A multicenter analysis of the significance of HLA matching on outcomes after kidney-pancreas transplantation.

Lo A, Stratta RJ, Alloway RR, Hodge EE; PIVOT Study Group. Lo A, et al. Among authors: hodge ee. Transplant Proc. 2005 Mar;37(2):1289-90. doi: 10.1016/j.transproceed.2004.12.212. Transplant Proc. 2005. PMID: 15848699 Clinical Trial.

4

A multicenter trial of two daclizumab dosing strategies versus no antibody induction in simultaneous kidney-pancreas transplantation: interim analysis.

Stratta RJ, Alloway RR, Lo A, Hodge E. Stratta RJ, et al. Transplant Proc. 2001 Feb-Mar;33(1-2):1692-3. doi: 10.1016/s0041-1345(00)02644-0. Transplant Proc. 2001. PMID: 11267472 Clinical Trial. No abstract available.

5

Two-dose daclizumab regimen in simultaneous kidney-pancreas transplant recipients: primary endpoint analysis of a multicenter, randomized study.

Stratta RJ, Alloway RR, Lo A, Hodge E. Stratta RJ, et al. Transplantation. 2003 Apr 27;75(8):1260-6. doi: 10.1097/01.TP.0000062838.38351.2A. Transplantation. 2003. PMID: 12717213 Clinical Trial.

6

Comparison of OKT3 with ALG for prophylaxis for patients with acute renal failure after cadaveric renal transplantation.

Steinmuller DR, Hayes JM, Novick AC, Streem SB, Hodge E, Slavis S, Martinez A, Graneto D, Pearce G. Steinmuller DR, et al. Transplantation. 1991 Jul;52(1):67-71. doi: 10.1097/00007890-199107000-00014. Transplantation. 1991. PMID: 1677502 Clinical Trial.

7

Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil--a prospective randomized study. Steroid Withdrawal Study Group.

Ahsan N, Hricik D, Matas A, Rose S, Tomlanovich S, Wilkinson A, Ewell M, McIntosh M, Stablein D, Hodge E. Ahsan N, et al. Transplantation. 1999 Dec 27;68(12):1865-74. doi: 10.1097/00007890-199912270-00009. Transplantation. 1999. PMID: 10628766 Clinical Trial.

8

A prospective, randomized, multicenter study evaluating the safety and efficacy of two dosing regimens of daclizumab compared to no antibody induction in simultaneous kidney-pancreas transplantation: results at 3 years.

Stratta RJ, Alloway RR, Lo A, Hodge EE. Stratta RJ, et al. Among authors: hodge ee. Transplant Proc. 2005 Oct;37(8):3531-4. doi: 10.1016/j.transproceed.2005.09.058. Transplant Proc. 2005. PMID: 16298651 Clinical Trial.

9

The impact of delayed graft function of the kidney on the pancreas allograft in simultaneous kidney-pancreas transplantation.

Reddy KS, Stratta RJ, Alloway RR, Lo A, Hodge EE; PIVOT Study Group. Reddy KS, et al. Among authors: hodge ee. Transplant Proc. 2004 May;36(4):1078-9. doi: 10.1016/j.transproceed.2004.04.052. Transplant Proc. 2004. PMID: 15194374 Clinical Trial.

10

Risk factors and outcomes analyses at 36 months of a prospective, randomized, multicenter, trial of daclizumab induction in simultaneous kidney-pancreas transplant recipients.

Stratta RJ, Alloway RR, Lo A, Hodge EE. Stratta RJ, et al. Among authors: hodge ee. Transplant Proc. 2005 Oct;37(8):3527-30. doi: 10.1016/j.transproceed.2005.09.061. Transplant Proc. 2005. PMID: 16298650 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters